Eli Lilly (LLY), Boehringer Get Positive Opinion from EMA CHMP for Trajenta Type 2 Diabetes Treatment
Tweet Send to a Friend
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced that they have received a Positive Opinion from the European ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
